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Abstract
Background: The de Morton Mobility Index (DEMMI) is a new mobility instrument that overcomes the limitations
of existing instruments. It is the first mobility instrument that accurately measures the mobility of all older adults.
The aim of this study was to provide a detailed report of investigations of the validity, responsiveness to change
and minimal clinically important difference (MCID) of the DEMMI during its development in an older acute medical
population.
Methods: This study was conducted using a head to head comparison design in two independent samples of
older acute medical patients (development sample, n = 86; validation sample, n = 106). Consecutive patients (≥65
years) were assessed using the DEMMI, Barthel Index (BI) and Hierarchical Assessment of Balance and Mobility
(HABAM) within 48 hours of hospital admission and discharge. Convergent and discriminant validity were
investigated using Spearman’s rho and known groups validity was investigated using a independent t test to
compare DEMMI scores for patients who were discharged to home compared to inpatient rehabilitation. Criterion
and distribution based methods were employed for estimating instrument responsiveness to change and the
MCID.
Results: Significant moderate to high correlations were identified between DEMMI and BI scores (r = 0.76 and r =
0.68) and DEMMI and HABAM scores (r = 0.91 and r = 0.92) in both samples. In both samples, DEMMI scores for
patients who were discharged to home were significantly higher than for patients discharged to inpatient
rehabilitation and provided evidence of known groups validity. Patients who were discharged to inpatient
rehabilitation (n = 8) had a mean DEMMI score of 50.75 (sd = 11.29) at acute hospital discharge compared to
patients who were discharged to home (n = 70) with a mean DEMMI score of 62.14 (sd = 18.41). MCID estimates
were similar across samples using distribution and criterion based methods. The MCID for the DEMMI was 10
points on the 100 point interval scale. The DEMMI was significantly more responsive to change than the BI using
criterion and distribution based methods in the validation sample.
Conclusion: This study has validated the DEMMI in two independent samples of older acute medical patients.
Estimates of its responsiveness and MCID have also been established. This study confirms that the DEMMI
overcomes the limitations of the BI and HABAM and provides an advanced method for objectively assessing
mobility for older acute medical patients.
* Correspondence: Natalie.DeMorton@nh.org.au; jenny.keating@monash.edu
1School of Primary Health Care, Faculty of Medicine, Nursing and Health
Sciences, Monash University - Peninsula Campus, PO Box 527, Frankston,
Victoria, 3199, Australia
Full list of author information is available at the end of the article
de Morton et al. BMC Geriatrics 2010, 10:72
http://www.biomedcentral.com/1471-2318/10/72
© 2010 de Morton et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Background
Despite the many health benefits of maintaining physical
independence in older age, two systematic reviews [1,2]
identified no mobility instrument that could accurately
measure and monitor changes in mobility for older
patients from the acute hospital setting back to full
health in the community. These findings led to the
development and validation of the de Morton Mobility
Index (DEMMI) in the acute hospital setting. The
DEMMI was designed to overcome the limitations of
existing instruments and was developed based on the
Rasch model [3].
Clinimetrically sound instruments are essential to
assist healthcare professionals to accurately measure and
monitor changes in patient health, to assess the efficacy
of interventions and to facilitate goal setting for thera-
peutic intervention. Instrument measurement properties,
such as validity, responsiveness to change and the mini-
mal clinically important difference (MCID) are required
for confidence in interpretation of measurements. Dur-
ing instrument development, it is also important to
establish that measurement properties are acceptable
and that measurement stability is confirmed in an inde-
pendent validation sample.
Validity refers to the extent to which inferences can
be made from measurements based on the ability of the
instrument to measure the construct of interest. There
are many different types of validity that can be estab-
lished using a variety of methods. Traditionally, validity
has been established by content, criterion and construct
validity [4]. However, there has been a proliferation of
arguments regarding different methods for validating
the extent to which measurements capture relevant
information.
Face validity relates to whether the items appear, on
the surface, to be measuring the construct of interest.
Content validity refers to extent to which the test con-
tent is relevant to and representative of the construct of
interest. Both face and content validity are usually
obtained through the consensus of experts in the field.
Construct validity is now generally considered to be
an overarching concept that encompasses criterion, con-
vergent, discriminant and known groups validity [4].
Evidence for construct validity is obtained by showing
that a test is related to performance on other theoreti-
cally related tests.
Criterion validity refers to the correlation of a scale
with a direct measure of the construct of interest. In the
absence of a ‘gold standard’ measure for the construct
of interest (as is the case for the construct of mobility),
convergent, discriminant and known groups validity can
be investigated to obtain evidence for construct validity.
Evidence for convergent validity is provided if test
scores correlate with other measures of the same con-
struct and evidence of discriminant validity is estab-
lished if scale scores do not correlate with measures of
unrelated constructs. Evidence of known groups validity
is obtained if groups who are known to differ on the
construct of interest score differently on the test. Predic-
tive validity can also provide evidence of construct valid-
ity by indicating scores on one variable predicting
outcome on another variable.
Responsiveness refers to the extent to which a measure-
ment tool can detect important change. The importance
of the concept of ‘responsiveness’ or ‘sensitivity to change’
is debated: some argue that responsiveness is a less impor-
tant measurement requirement than reliability and valid-
ity, others contend that responsiveness provides evidence
of validity and yet others propose that responsiveness is
the most important quality of measurements [5].
In a systematic review of the responsiveness of health
related quality of life instruments, Terwee et al. [5] iden-
tified 31 responsiveness indices. Most indices could be
classified as either evaluating change over time (distribu-
tion based methods) or clinically important change over
time (criterion based methods). They concluded that
comparisons of the responsiveness of different instru-
ments can lead to different conclusions depending on
the index selected. For the purposes of evaluating exist-
ing mobility instruments in this study both distribution
and criterion based methods were planned.
The MCID was defined by Jaeschke, Singer and
Guyatt [6] as “the smallest difference in score in the
domain of interest which patients perceive as benefi-
cial.......” The MCID provides clinicians with the change
in scores that patients perceive to represent an impor-
tant amount of change.
We have argued [7] that the reliability of an instru-
ment is an important measurement property as it pro-
vides clinicians and researchers with an estimate of
measurement error associated with instrument applica-
tion. The minimal change that exceeds error in 90% of
cases (MDC90) has been repeatedly verified for the
DEMMI as 9/100 points on the Rasch converted interval
scale [3,7].
The aim of this study was to investigate the validity,
responsiveness to change and the MCID for Rasch con-
verted DEMMI scores obtained in two independent
samples. In the DEMMI development sample, a subset
of 17 mobility items was selected from a larger pool of
42 tested items to construct the DEMMI. These items
fitted the Rasch model and therefore provided evidence
that a unidimensional mobility instrument had been
achieved [3]. In the DEMMI validation sample, these 17
items were tested and 2 items were subsequently
removed. It is theoretically plausible that items might
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items (i.e. 17 items within a pool of 42 tested items) due
to learning or fatigue effects compared to the final set of
15 item DEMMI. Nevertheless it was expected that the
DEMMI development study would provide data to esti-
mate the measurement properties required to interpret
scores obtained using the DEMMI before proceeding to
the next stage of instrument development. Clinimetric
data obtained from the development sample also pro-
vided estimates for comparison with estimates obtained
in the independent validation sample.
As part of validation against a reference standard,
comparison with other instruments that have been
used to measure mobility was planned. In order to
compare the performance of different instruments that
propose to measure the same underlying construct, a
head-to-head comparison was the preferred design.
Data obtained for different instruments from different
samples could provide misleading evidence of relative
utility as factors such as sample variance affect estima-
tions. These confounders can be countered when com-
parisons of measurement properties are made using
data collected at the same point in time from the same
participants. We therefore included in this study a
head-to-head comparison of the DEMMI with the
Barthel Index [8] and Hierarchical Assessment of
Balance and Mobility (HABAM) [9] in two indepen-
dent samples of older acute medical patients.
Methods
Data were collected as previously reported by de Morton,
Davidson and Keating (2008) [3] in two independent
samples of older acute medical patients. Participants
were acute medical patients admitted to The Northern
Hospital, Australia who were aged 65 years and older.
Written and informed consent was obtained from each
participant (either first or third party consent) within 48
hours of admission. In the DEMMI development sample
(n = 89), 42 mobility items were tested (de Morton,
Davidson, Keating. The development of the de Morton
Mobility Index (DEMMI) in an older acute medical
population: item reduction using the Rasch model
(PART 1). Submitted) and in the DEMMI validation
sample (n = 106), 17 DEMMI items were tested on each
participant within 48 hour of admission and every
48 hours until discharge from the acute hospital setting
(de Morton, Davidson, Keating. The development of the
de Morton Mobility Index (DEMMI) in an independent
sample of older acute medical patients: refinement and
validation using the Rasch model (PART 2). Submitted).
This study was approved by the Northern Health and
Monash University Human Ethics Committees.
Activity limitation measures that were selected for a
head-to-head comparison with the DEMMI mobility
items were the Barthel Index (BI) [8] and the HABAM
[9]. The BI is one of the most widely used functional
outcome measures and the HABAM was identified in a
systematic review [1] to have the most desirable clini-
metric properties of existing mobility outcome measures
for an older acute general medical population. The
modified BI [8] was employed in this study as this was
the version already in use in a concurrent randomised
controlled trial that included the same patient popula-
tion at The Northern Hospital.
The modified BI is an ordinal scale that provides a
total score between 0 and 100 where higher scores indi-
cate greater independence in activities of daily living [8].
The HABAM is an interval level mobility instrument
that provides a score between 0 and 26 [9]. Higher
scores indicate increasing levels of independent patient
mobility. In addition, the MMSE was conducted at each
assessment. The MMSE is reported to be a valid and
reliable measure of patient cognition [10]. It provides a
score between 0 and 30 points where increasing scores
indicate higher cognitive ability.
At each assessment, a research assistant administered
the BI and the MMSE. The BI was administered by scor-
ing patient response when asked each item on the scale.
If the patient was confused or disorientated to time,
place or person, the BI was administered by interviewing
the ward nurse caring for the patient or a family member.
As close as possible after the completion of the BI and
MMSE, the patient was asked to complete the physical
performance mobility items by the research physiothera-
pist, who was blinded to the BI score. The BI was always
administered first so that BI self report scores were not
influenced by patient performance on the mobility items.
There was no persuasive reason why self report BI scores
would influence physical performance on the mobility
items. This method allowed a blinded head-to-head com-
parison of the DEMMI mobility items with the BI.
Only one item on the HABAM, unlimited walking,
was not included in the mobility items for testing as it
could not be objectively assessed. A patient was deemed
to have successfully completed the unlimited walking
item on the HABAM if they completed the 50 meter
walk independently without a gait aid item with ease.
Since all of the other items contained in the HABAM
were tested with the mobility items, the HABAM item
scoring protocols were applied and a HABAM score was
obtained post hoc after viewing the mobility items. A
HABAM score was recorded for each mobility assess-
ment by the research physiotherapist. This permitted a
practical but non blinded head-to-head comparison of
the HABAM with the DEMMI.
Concurrent with collection of measurements using the
DEMMI, HABAM and BI, data were also gathered using
ag l o b a lr a t i n go fc h a n g e( G R C )s c a l et op r o v i d ea
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and the MCID. At each 48 hour assessment the patient
and therapist completed the global change scale (5 point
scale: much worse, bit worse, same, bit better, much
better) comparing each patient’s current mobility status
to their mobility at admission assessment. An important
limitation associated with this method of criterion based
assessment is that responses can be influenced by many
factors. Recall bias and cognitive impairment (chronic or
acute) were deemed to be the factors most likely to con-
found GRC in this study. In addition, it was possible
that patient’s perceptions of the influence of their
responses on decisions regarding readiness for discharge
and discharge destination might also influence some
patient reports of change in mobility status.
Significant cognitive impairment would also render
some patients incapable of providing a valid GRC. To
ensure that at least one GRC score was obtained for
each patient who completed a 48 hour mobility assess-
ment, therapist GRC was also recorded at each 48 hour
assessment. This also provided data for comparing glo-
bal change scores obtained by patients and therapists.
Many different GRC scales have been reported and
vary considerably in the number of response options
offered to raters. Streiner and Norman (1995) [4] argued
that the minimum number of categories used by raters
should be in the region of five to seven and that most
people are unable to discriminate beyond seven cate-
gories. In the present study, response options were kept
to the recommended minimum of five. This was done
to maximise patient participation across the broad range
of anticipated cognitive ability and with consideration of
the significant proportion of people for whom English
was not a primary language. A 5 point scale was
adopted in the absence of arguments for an alternate
method. It appeared to provide response options to dis-
criminate between important categories of change in a
simple and practical form.
Data analysis
Rasch-converted interval level DEMMI scores from data
gathered from older acute medical patients in the devel-
opment (n = 86) and validation (n = 106) samples were
used to investigate clinimetric properties of the DEMMI
and to compare these properties to those of the BI and
HABAM. Data analysis was performed using SPSS 12.0
(SPSS Inc., Chicago, USA) and Microsoft Excel 2002
(Microsoft Corporation, Redmond, USA).
In the DEMMI development sample, clinimetric prop-
erties were calculated from the 17 item DEMMI (i.e. the
jog and single leg balance with eyes closed items were
included) [3]. In the validation sample these were calcu-
lated for the 15 item DEMMI (i.e. the jog and single leg
balance with eyes closed items were not included) [3].
Validity
The following a priori hypotheses were tested to investi-
gate convergent, discriminant and known groups validity
for the DEMMI.
A priori hypotheses:
1. Convergent validity: DEMMI scores will have a
significant and high correlation with BI and
HABAM scores.
2. Discriminant validity: DEMMI scores will have
low correlation with the MMSE, APACHE 11 sever-
ity of illness and Charlson co-morbidity scores.
3. Known groups validity: Patients who are dis-
charged to home will have significantly higher
DEMMI scores at hospital discharge than patients
discharged to rehabilitation.
A Pearson’s correlation coefficient or Spearman’sr h o
and associated 95% confidence interval were calculated
to investigate the convergent and discriminant validity
of the DEMMI. To investigate the known groups valid-
ity, an independent t test was performed to compare
mobility scores at hospital discharge for patients
who were discharged to home compared to inpatient
rehabilitation.
Responsiveness
Measurement responsiveness was calculated using acute
hospital admission and discharge scores on the DEMMI,
HABAM and BI. Two responsiveness indices were
selected ap r i o r i . A superior responsiveness index has
not been reported in the literature and therefore indices
were selected primarily due to their simplicity and
known methods for calculating a 95% confidence inter-
val. A distribution based index, the Effect Size Index
(ESI) [11], and a criterion based index, Guyatt’s Respon-
siveness Index (GRI) [12], were calculated for each
activity limitation outcome measure. These indices were
calculated using the following formulas:
ESI
averagechange
standarddeviationof initialscores
=
GRI
averagechangeinchange group
standarddeviationof changeins
=
t table group
For both the ESI and GRI, the 95% confidence interval
was calculated by initially calculating the standard error
of the estimate of the mean change in scores between
admission and a subsequent test (change score sd/
() n −1 ). These values were then adjusted for 95%
confidence and inserted into the numerator of each
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95% confidence interval for both indices.
GRI was calculated twice, once using patient GRC
scores and again using therapist GRC scores. It has been
argued that when patients rate their change as the
‘same’, ‘bit better’ or ‘bit worse’ it is unlikely that clini-
cally important change has occurred [13,14]. Subse-
quently, patients in the categories of either ‘bit better’ or
‘bit worse’ were reclassified as ‘unchanged’ and also
included in the reliability analysis [7]. Patient and thera-
pist were not required to have absolute agreement about
rating (i.e. ‘bit worse’, ‘same’ or ‘bit better’)a n dw e r e
classified as ‘unchanged’ if both opted for any one of
those three responses. Decisions rules for identifying
‘changed’ and ‘unchanged’ patients for analyses were
established a priori.
In this study, the responsiveness of the DEMMI was
compared to the responsiveness of the BI and the
HABAM using the ESI and GRI based on patient and
therapist rating of change. Tryon (2001) [15] provides a
useful method for adjusting for error in point estimates
for multiple pairwise comparisons. Tryon established
that the 95% confidence bands of two independent
means can overlap yet remain significantly different at
the 0.05 level. If the standard errors of two independent
means are equal, Tryon reported non overlapping 84%
confidence bands to indicate a significant difference
between means. Using the methods described by Tryon
[15], the width of inferential confidence bands are deter-
mined by tcrit and a factor of E whilst maintaining an
overall alpha level of 0.05 for multiple comparisons. Tcrit
is determined by the number of pairwise comparisons
and degrees of freedom (based on sample size). E is
defined by Tryon as the “ratio of the standard error of
the difference between groups to the sum of the stan-
dard errors of both groups.” When data are presented
using graphs that demonstrate group means and Tryon
adjusted 95% confidence bands, statistical difference for
any pairwise comparison can be inferred when confi-
dence intervals do not overlap.
Minimal clinically important difference
The MCID was calculated for the DEMMI, HABAM
and BI using distribution and criterion based methods.
The distribution based approach recommended by Nor-
man et al. (2003) [16] was employed by using half the
baseline standard deviation of admission scores as a best
estimate of the MCID.
Clinically important change was considered to have
occurred for patients who were rated as ‘much better’ at
discharge assessment. Criterion based MCID estimates
were obtained by calculating the average change in
DEMMI scores for the ‘changed group’ between hospital
admission and discharge. A criterion based MCID
estimate was obtained using patient, therapist and when
either therapist or patient reported they were ‘much
better’.
Results
DEMMI, HABAM and BI assessments were completed
at initial assessment for patients in the development
(n = 86) and validation samples (n = 106). The charac-
teristics of participants and the flow of participants in
this study have been previously reported [3].
Distribution of activity limitation scores at hospital
admission
The distribution of activity limitation scores at hospital
admission were consistent across the two independent
samples. Initial scores for the HABAM and BI were not
normally distributed and had a ceiling effect. In contrast,
initial DEMMI scores were normally distributed and did
not display floor or ceiling effects in either sample
(Figures 1a-c). In the validation sample, normal distribu-
tion of DEMMI scores was evidenced by similar mean
and median scores, 69.8% of scores lying within one stan-
dard deviation (31 to 72) of the mean and skewness and
kurtosis indices were -0.23 and 0.24 respectively. Only 3
patients (2.8%) scored above 90 and 5 patients (4.7%)
scored less than 10 at their initial assessment. For the BI,
43% of patients scored 90 or higher and for the HABAM,
26% of patients scored either 25 or 26 at hospital admis-
sion. Table 1 shows the mean initial DEMMI scores for
each major diagnostic category within the general medi-
cal patient population and indicates that the DEMMI has
the scale width required to measure and monitor changes
in mobility for each of these diagnostic groups.
Activity limitation change scores between hospital
admission and discharge
Of the 106 patients included in the validation study, 67
patients had at least two assessments completed. Of
these 67 patients, a therapist GRC score between hospi-
tal admission and discharge was obtained for 57 patients
and a patient GRC score was obtained for 61 patients.
The 6 patients who did not complete a GRC score were
significantly older (p = 0.02) than patients who did com-
plete a GRC score but were similar on all other baseline
characteristics.
Table 2 shows patient and therapist GRC scores and
accompanying change scores for the 15 item DEMMI,
the HABAM and BI between acute hospital admission
and discharge. Consistent with findings in the develop-
ment sample, most patients were reported to improve in
their mobility between acute hospital admission and dis-
charge. No patients were reported to be ‘much worse’ by
the therapist and there was only one report of ‘much
worse’ by a patient. Two patients were reported by the
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Page 6 of 12therapist to be a ‘bit worse’ and three patients were rated
by patients to be a ‘bit worse.’ Change scores between
rating categories for patients reported to be ‘bit worse’,
‘same’ or ‘bit better’ (i.e. were classified as ‘unchanged’)
were small. An independent t test identified no statisti-
cally significantly difference for change scores between
patients reported to be the ‘same’ or ‘bit better.’ There
were too few patients in the ‘bit worse’ category to pro-
vide meaningful point estimates for comparison.
For patients classified as ‘unchanged’ based on patient
report of change, scores were significantly higher at hos-
pital discharge compared to hospital admission for the
DEMMI and HABAM but not for the BI (Table 3). For
patients classified as ‘unchanged’ by the therapist, scores
for the DEMMI, HABAM and BI were not significantly
different at hospital admission compared to discharge
(Table 3).
For patients classified as ‘changed’ by the patient and
the therapist, DEMMI, HABAM and BI scores were sig-
nificantly higher at hospital discharge compared to hos-
pital admission (Table 3). However, a broad range of
change scores were classified as both ‘changed’ and
‘unchanged’ by both patients and therapist.
Validity
Convergent validity
Evidence of convergent validity for the DEMMI was
obtained in both samples by identifying a significant and
high correlation with HABAM scores (Development
sample: Pearson’s r = 0.92, 95% CI 0.88 to 0.95, p =
0.00; Validation sample: Pearson’s r = 0.91, 95% CI 0.87
to 0.94, p = 0.00, n =1 0 6 ,F i g u r e2 )a n dam o d e r a t et o
high correlation with BI scores (Development sample:
Spearman’s rho = 0.76 95% CI 0.65 to 0.84, p = 0.00;
Validation sample: Spearman’s rho = 0.68 95% CI 0.56
to 0.77, p = 0.00, n = 105, Figure 3) at initial assessment.
The relationship between these measures was obscured
by the HABAM and BI ceiling effect.
Discriminant validity
Discriminant validity for the DEMMI was evidenced in
both samples by a low correlation with measures of
other constructs. Initial DEMMI scores had a significant
but low correlation with the MMSE (Development sam-
ple: Spearman’s rho = 0.36 95% CI 0.16 to 0.53, p =
0.00, n = 85; Validation sample: Spearman’s rho = 0.24,
95% CI 0.05 to 0.41, p = 0.02, n = 103), and low and
non significant correlations with APACHE 11 severity of
illness scores (Development sample: Spearman’sr h o=
-0.11 95% CI -0.32 to 0.11, p = 0.34, n =8 3 ;Validation
sample: Spearman’s rho = 0.07, 95% CI -0.12 to 0.26,
p = 0.49, n = 105) and Charlson co-morbidity index
scores (Development sample: Spearman’s rho = -0.19
95% CI -0.39 to 0.03, p = 0.08, n =8 4 ;Validation
sample: Spearman’s rho = -0.04, 95% CI -0.23 to 0.15,
p = 0.68, n = 105).
Known groups validity
In both samples, an independent t test showed that
patients who were discharged to inpatient rehabilitation
had significantly lower DEMMI scores at acute hospital
discharge than those discharged to home, providing evi-
dence of known groups validity for the DEMMI. In the
development sample, patients discharged to inpatient
rehabilitation (n = 11) had a mean DEMMI score of
39.55 (sd = 9.41, 95% CI 33.72 to 45.38) and patients
discharged to home (n = 62) had a mean DEMMI score
of 59.61 (sd = 13.22, 95% CI 56.30 to 62.93) (p = 0.00).
In the validation sample, patients who were discharged
Table 1 Initial DEMMI scores for each diagnostic group in
the validation study
Diagnostic group n Mean (sd)
Respiratory 37 55.95 (22.06)
Cardiovascular 21 59.10 (11.11)
Digestive 7 50.29 (18.45)
Endocrine 6 38.17 (21.97)
Genitourinary 6 43.67 (22.32)
Other 29 44.83 (22.39)
Table 2 Global rating of change scores and DEMMI (0 - 100), HABAM (0 - 26) and BI (0 - 100) mean change scores (sd)
between hospital admission and discharge in the validation study
Much worse Bit worse Same Bit better Much better
Therapist n =0 n =2 n =6 n =2 6 n =2 3
DEMMI NA -16.50 (3.54) +3.67 (4.76) +3.31 (7.19) +14.00 (9.19)
HABAM NA 0 (0) 0.43 (3.55) +0.85 (2.98) +4.70 (3.94)
Barthel Index NA -1* -1.43 (15.04) -0.15 (11.95) +8.09 (11.00)
Patient n =1 n =3 n =7 n =1 4 n =3 5
DEMMI -19 -1.67 (10.69) +10.14 (11.60) +6.64 (9.25) +9.43 (10.56)
HABAM 0 -2.00 (3.46) +2.43 (4.04) +2.29 (4.50) +3.11 (3.92)
Barthel Index NA* -9.33 (15.31) +11.5 (12.60)* -1.64 (11.87) +5.89 (12.13)
NA = Not applicable.
* one BI assessment not obtained.
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score of 50.75 (sd = 11.29, 95% CI 42.39 to 59.11) at
discharge compared to patients who were discharged to
home (n = 70) with a mean DEMMI score of 62.14
(sd = 18.41, 95% CI 57.80 to 66.49). An independent t
test of discharge DEMMI assessment scores for these
two groups showed these scores to be significantly
different (p = 0.03).
Responsiveness to change
In the development sample, there was no significant
difference identified between the responsiveness of
DEMMI and HABAM measurements or DEMMI and BI
measurements using the ESI or GRI based on patient or
therapist report of change. This is shown by overlapping
Tryon adjusted inferential confidence intervals in
Figures 4a-c.
Table 3 DEMMI, HABAM and BI scores for patients rated ‘unchanged’, ‘same’ and ‘changed’ in the validation study
n Admission mean (sd) Discharge
mean (sd)
p value n Admission mean (sd) Discharge
mean (sd)
p value
Patient rating of change Therapist rating of change
Unchanged (’bit worse’, ‘same’ or ‘bit better’)
DEMMI 24 45.38
(18.59)
52.00
(19.77)
0.01* 34 52.29
(20.19)
54.50
(20.21)
0.12
HABAM 24 15.00
(6.58)
16.83
(6.66)
0.05* 34 17.09
(6.55)
17.76
(6.04)
0.20
BI 23 76.35
(18.17)
77.13
(25.05)
0.79 34 81.41
(21.05)
81.79
(22.07)
0.86
Same
DEMMI 7 48.14
(24.33)
58.29
(29.55)
0.06 6 45.67
(24.37)
49.33
(26.42)
0.12
HABAM 7 15.29
(8.67)
17.86
(9.46)
0.14 6 15.67
(8.36)
15.83
(9.00)
0.92
BI 6 73.5
(16.21)
85.0
(24.23)
0.08 6 77.17
(19.14)
75.50
(29.57)
0.81
Changed (’much better’)
DEMMI 35 53.06
(18.31)
62.49
(15.56)
0.00* 23 48.22
(14.89)
62.22
(13.55)
0.00*
HABAM 35 16.83
(6.18)
19.94
(4.81)
0.00* 23 15.17
(5.75)
19.87
(4.87)
0.00*
BI 35 82.34
(22.42)
88.23
(15.13)
0.01* 23 81.35
(20.32)
89.43
(15.86)
0.00*
*p < 0.05.
Figure 2 Scatterplot of DEMMI and HABAM scores at initial assessment in the validation study.
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Page 8 of 12However, in the validation sample, using the ESI and
GRI based on patient report of change and GRI based
on therapist report of change, DEMMI measurements
w e r es i g n i f i c a n t l ym o r er e s p o n s i v et oc h a n g et h a nt h e
BI but not the HABAM (Figures 5a-c). For the ESI, GRI
based on patient report of change and GRI based on
therapist report of change, tcrit was calculated to be
2.28, 2.34 and 2.40 respectively.
Minimal clinically important difference
Criterion based MCID
The MCID was estimated by calculating the average
change in DEMMI score for the ‘changed’ group
between hospital admission and discharge. Table 4
shows similar criterion based MCID estimates obtained
using patient, therapist, and patient or therapist ratings
of change from both samples. Patient report led to esti-
mates of clinically important change in mobility that
were smaller than those based on therapist report in
both samples.
Distribution based MCID
Using Norman et al.’s [16] distribution based method,
the MCID was calculated to be 8.00 and 10.46 points
for the DEMMI in the development and validation sam-
ples respectively. The MCID for the HABAM and BI
were also obtained using this distribution based method
and were calculated to be 3.4 out of 26 and 11.4 out of
100 points respectively in the development sample. In
the validation sample, the MCID for the HABAM and
BI were also obtained using this method and were cal-
culated to be 3.39 and 9.43 points respectively.
Discussion
In this study the measurement properties of the
DEMMI have been validated in two independent sam-
ples of older acute medical patients. In a repeated head-
to-head comparison with the HABAM and BI, this
study also confirmed the superior measurement proper-
ties of the DEMMI and provides further evidence that
the DEMMI offers researchers and clinicians a superior
Figure 3 Scatterplot of DEMMI and BI scores at initial assessment in the validation study.
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Figure 4 a, b & c. Development sample: a) Effect Size Index with 87.3% confidence intervals. b) Guyatt’s Responsiveness Index based on
patient rating of change with 88.3% confidence intervals. c) Guyatt’s Responsiveness Index based on therapist rating of change with 89.5%
confidence intervals.
de Morton et al. BMC Geriatrics 2010, 10:72
http://www.biomedcentral.com/1471-2318/10/72
Page 9 of 12method for measuring and monitoring changes in mobi-
lity for older acute medical patients.
The DEMMI was confirmed in the validation sample
t ob eab r o a ds c a l ew i t hf e wp a t i e n t ss c o r i n gw i t h i nt h e
MDC90 (9 points) of the scale extremes. The DEMMI
did not have a floor or ceiling effect and had the scale
width required to measure improvement and deteriora-
tion in mobility for each of the most common medical
diagnostic subgroups within an older general medical
population. In contrast, a ceiling effect was confirmed
for both the BI and HABAM with a large proportion of
patients scoring at the upper scale extreme at their
initial assessment. Since the DEMMI has a broad scale
width and is safe and practical for application in older
acute medical patients, the DEMMI also has the poten-
tial to measure changes in mobility after acute hospital
discharge (e.g. in the subacute hospital or community
settings).
Similar evidence of scale convergent, discriminant and
known groups validity was observed in the development
and validation samples. The DEMMI had high correla-
tion with measures of related constructs (the HABAM
and BI), low correlation with measures of other con-
structs (MMSE, APACHE 11 and Charlson co-morbidity
Index) and patients who were discharged to home had
significantly higher DEMMI scores than patients who
were discharged to inpatient rehabilitation.
In the development sample, there were no significant
differences in the responsiveness of DEMMI compared
to HABAM or BI measurements. The DEMMI had the
highest responsiveness point estimate using the ESI and
GRI based on patient ratings of change. However, the
HABAM had the highest responsiveness index using
GRI based on therapist rating of change scores. It was
observed that the denominator in calculations of GRI
for the HABAM (based on therapist rating of change
scores) was much smaller than for the DEMMI and
thus a larger responsiveness index was obtained for the
HABAM. Closer examination of the raw data revealed
that due to the HABAM ceiling effect, the standard
deviation of initial scores for the unchanged group was
relatively small. This indicates that for an instrument
with a known ceiling effect such as the HABAM (that is
therefore not responsive to change at the upper end of
its scale) an artificially inflated criterion based respon-
siveness index can result from inadequate scale width.
Although the responsiveness of the BI and HABAM
was not a comparison of interest in this study, Mac-
Knight and Rockwood (1995) [17] reported the HABAM
to be more responsive to change than the BI in an older
acute medical population. Compared to estimates in this
study, MacKnight and Rockwood reported a higher ESI
of 0.51 for the HABAM and 0.35 for the BI. However,
distribution based methods of calculating responsiveness
to change are dependent on the magnitude of change
that a group undergoes between assessments and is
therefore population dependent. The patient population
in this study was, on average, more independent in their
Figure 5 a, b & c. Validation sample: a) Effect Size Index with 83.7% confidence intervals. b) Guyatt’s Responsiveness Index based on patient
rating of change for with 84.4% confidence intervals. c) Guyatt’s Responsiveness Index based on therapist rating of change with 84.9%
confidence intervals.
Table 4 Criterion and distribution based MCID estimates for the DEMMI
Criterion method Distribution method
Patient
(n = 23)
Therapist
(n = 21)
Patient or therapist
(n = 31)
Development sample MCID
(95% CI)
7.78
(5.28 to 10.28)
10.43
(7.74 to 13.11)
8.45
(6.09 to 10.81)
8.00
Patient
(n = 35)
Therapist
(n = 23)
Patient or therapist
(n = 42)
Validation sample
MCID (95% CI)
9.43
(5.92 to 12.92)
14.00
(10.24 to 17.75)
9.71
(6.66 to 12.72)
10.46
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Page 10 of 12activities of daily living and mobility at hospital admis-
sion than patients in the study reported by MacKnight
and Rockwood. This may account for differences
between study results. In addition, only 28 patients were
included in the study reported by MacKnight and Rock-
wood and their conclusions appear to be based on the
ranking of ESI point estimates, as the 95% confidence
intervals surrounding these indices were not provided in
the published report. These authors also reported the
H A B A Mt ob et h r e et i m e sm o r er e s p o n s i v et oc h a n g e
than the BI using the relative efficiency index. However,
the relative efficiency was not calculated in this study as
there are no established methods for calculating the 95%
confidence interval for this responsiveness index.
In contrast to the development sample in this study,
responsiveness indices in the validation sample identified
t h eD E M M It ob es i g n i f i c a n t l ym o r er e s p o n s i v et o
change than the BI using the ESI and GRI (based on
patient and therapist report of change). No significant dif-
ference was identified between the responsiveness of the
DEMMI and the HABAM using either the ESI or GRI.
Although responsiveness indices were calculated for the
17 item instrument in the development sample and for
the 15 item instrument in the validation sample, these
results highlight the sample dependency of responsiveness
indices. Different results can be obtained in different
samples as the DEMMI was identified to be significantly
more responsive to change than the BI in the validation
sample but not in the instrument development sample.
For outcome measure application, it is optimal to pro-
vide one MCID index rather than different indices
obtained using different methods. After completing this
study, an MCID estimate of 10 points was added to the
final format of the DEMMI assessment form. This indi-
cates that a change score of 10 points or more is required
to represent a clinically important change in patient
mobility.
The MCID estimates obtained in the final validation
s t u d yw e r en o ts i g n i f i c a n t l yd i f f e r e n tt ot h ee s t i m a t e s
calculated from the instrument development sample.
Consistency of these measurement properties across
independent study samples also provides clinicians and
researchers with further confidence in the interpretation
and clinical application of DEMMI scores.
The MCID for the DEMMI, HABAM and BI represent
10.0%, 13.1% and 11.4% of the instrument scale widths
respectively. For the DEMMI, only 3 patients (2.8%)
scored above 90 and 5 patients (4.7%) scored less than 10
at their initial assessment in the validation sample and
therefore the DEMMI provided the scale width required
to adequately measure clinically important change for all
older acute medical patients included in this study. In
contrast, due to the HABAM and BI ceiling effect, these
instruments were unable to measure clinically important
change at the upper end of these scales for a large pro-
portion of older medical patients included in this study.
This study had limitations. For the known groups
validity analyses there were only 11 patients in the
development sample and 8 patients in the validation
sample who were discharged to inpatient rehabilitation.
In addition, the relatively small sample sizes for the
development (n = 86) and validation (n = 106) samples
may also explain some of the differences that were iden-
tified between samples in this study.
Conclusion
This study confirmed that the DEMMI is a valid mobility
instrument with consistent MCID estimates across inde-
pendent samples. These results indicate the validity of
clinical and research application of the DEMMI in an
older acute medical population. Estimates of responsive-
ness have also been reported. In a repeated head-to-head
comparison with the HABAM and BI, this study has con-
firmed that the DEMMI overcomes the limitations of
these two instruments and provides an advanced method
for objectively assessing and monitoring changes in
mobility for older acute medical patients.
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